研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章 · 第 23 页
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-05-17 到 2026-05-05。
按期刊、按主题看 →
SiM Spatial & Time Series · 发表于 2026-05-17,收录于 2026-05-22
Thuy V. Lu, Joshua D. Grill, Daniel L. Gillen, Maricela Cruz
摘要
Including participants from diverse neighborhoods in research may improve generalizability of study results to broader populations. The University of California Irvine Consent‐to‐Contact (C2C) Registry recently initiated a novel Recruitment Strategy Study (named the C2C‐RSS) to assess the effectiveness of interventions (Facebook versus traditionally mailed postcard advertisements) that aimed at recruiting individuals from more disadvantaged neighborhoods, as defined by high Area Deprivation Index (ADI) in Orange County, California. The C2C‐RSS utilized a nonrandom sampling design to ensure uniform inclusion across ADI deciles. The primary objective of the C2C‐RSS is to estimate a marginal intervention effect across all ADI deciles on recruitment to the C2C Registry. A key secondary objective is to assess effect modification by ADI strata. To adjust for sampling bias in the C2C‐RSS design, we extend the Robust‐Multiple Interrupted Time Series model to incorporate known sampling weights. We additionally propose two variance estimators. The first quantifies uncertainty of the unknown change point associated with the intervention in all mean function parameters. The second additionally accounts for mis‐specification of the mean model. We demonstrate the performance of our methods through empirical simulation studies. Further, we use our proposed methods to assess the design of the C2C‐RSS, illustrating comparable power for the primary endpoint and increased power for the secondary endpoint relative to a simple random sampling design.
JASA Bayesian Methods · 发表于 2026-05-17
Yang Ni
SiM Longitudinal Data Survival Analysis Bayesian Methods · 发表于 2026-05-17,收录于 2026-05-22
Marco Palma, Omar El Makkaoui, Ruth H. Keogh, Siobhán B. Carr, Rhonda Szczesniak, David Taylor‐Robinson, Angela M. Wood, Graciela Muniz‐Terrera, Jessica K. Barrett
摘要
Within‐individual variability of health indicators measured over time is becoming commonly used to inform about disease progression. Simple summary statistics (e.g., the standard deviation for each individual) are often used but they are not suited to account for time changes. In addition, when these summary statistics are used as covariates in a regression model for time‐to‐event outcomes, the estimates of the hazard ratios are subject to regression dilution. To overcome these issues, a joint model is built where the association between the time‐to‐event outcome and multivariate longitudinal markers is specified in terms of the within‐individual variability of the latter. A mixed‐effect location‐scale model is used to analyze the longitudinal biomarkers, their within‐individual variability and their correlation. The time to event is modeled using a proportional hazard regression model, with a flexible specification of the baseline hazard, and the information from the longitudinal biomarkers is shared as a function of the random effects. The model can be used to quantify within‐individual variability for the longitudinal markers and their association with the time‐to‐event outcome. We show through a simulation study the performance of the model in comparison with standard joint models with constant variance. The model is applied on a dataset of adult women from the UK cystic fibrosis registry, to evaluate the association between lung function, malnutrition and mortality.
SMMR Longitudinal Data Survival Analysis Nonparametric & Semiparametric · 发表于 2026-05-16
Xiaoyu Niu, Xuejing Zhao
摘要
Quantile regression (QR) offers a robust framework for analyzing covariate effects across the outcome distribution, particularly when the response variable exhibits skewness or heavy tails. To jointly model multivariate longitudinal biomarkers and a time-to-event outcome, we propose a novel joint model based on linear QR mixed models. The longitudinal submodel accounts for associations among multivariate responses by assuming a multivariate asymmetric Laplace distribution for the errors, utilizing its location-scale mixture representation for computational efficiency. For the event-time process, a Cox proportional hazards model is employed, which incorporates shared random effects from the longitudinal submodel to link the two processes. Estimation is performed using a Monte Carlo expectation-maximization algorithm, with Metropolis-Hastings sampling to approximate the E-step. Comprehensive simulations under various quantile levels, censoring rates, error distributions, and correlation structures demonstrate that the proposed method yields accurate estimates for the regression parameters in both the longitudinal and survival submodels. Finally, we illustrate the practical utility of the model by analyzing a dataset from a primary biliary cirrhosis study.
SMMR High-Dimensional Functional Data Networks & Graphs · 发表于 2026-05-15
Shuoyang Wang, Guanqun Cao, Yuan Huang
摘要
The opportunity to utilize multivariate functional data types for conducting classification tasks is emerging with the growing availability of imaging data. Inspired by the extensive data provided by the Alzheimer’s Disease Neuroimaging Initiative, we introduce a novel classifier tailored for multivariate functional data. Each observation in this framework may be associated with numerous functional processes, varying in dimensions, such as curves and images. Each predictor is a random element in an infinite-dimensional function space, and the number of functional predictors can potentially be much greater than the sample size. By adopting a sparse deep rectified linear unit network architecture and incorporating the LassoNet algorithm, the proposed functional Bayesian information criterion deep neural network performs feature selection and classification simultaneously, in contrast to existing functional data classifiers. This approach addresses the challenge of complex inter-correlation structures among multiple functional processes without requiring distributional assumptions. A simulation study and a real data application demonstrate its favorable performance.
Biometrics Causal Inference Meta-Analysis & Data Integration Econometrics & Economics · 发表于 2026-05-15,收录于 2026-05-17
Sijia Li, Rui Duan
摘要
In response to the growing need for generating real-world evidence from multisite collaborative studies, we introduce an efficient collaborative learning approach to evaluate average treatment effect (ECO-ATE) in a multisite setting under data-sharing constraints. Specifically, ECO-ATE operates in a federated manner, using individual-level data from a user-defined target population and summary statistics from other source populations, to construct efficient estimator for the average treatment effect on the target population of interest. Our federated approach does not require iterative communications between sites, making it particularly suitable for research consortia with limited resources for developing automated data-sharing infrastructures. Compared to existing work data integration methods in causal inference, ECO-ATE allows distributional shifts in outcomes, treatments, and baseline covariates distributions, and achieves semiparametric efficiency bound under appropriate conditions. We conduct simulation studies to demonstrate the extent of efficiency gains achieved by incorporating additional data sources, as well as the robustness of our approach against varying levels of distributional shifts and overparameterization, compared to existing benchmarks. We apply ECO-ATE to a case study examining the effect of insulin versus non-insulin treatments on heart failure for patients with type II diabetes using electronic health record data collected from the All of Us program.
SiM Causal Inference · 发表于 2026-05-15,收录于 2026-05-16
Cyrill Scheidegger, Simon Wandel, Tobias Mütze
摘要
Covariate adjustment can enhance precision and power in clinical trials, yet its application to the win odds remains unclear. The win odds is a treatment effect measure related to the win ratio. Both measures are based on pairwise comparisons between individuals in the treatment and the control group, and count the number of wins, losses, and ties from these pairwise comparisons. Importantly, the win odds treats ties as half a win for each group. A priori, it is not clear how covariate adjustment can be implemented for the win odds. To address this, we establish a connection between the win odds and the marginal probabilistic index, a measure for which covariate adjustment theory is well‐developed. Using this connection, we show how covariate adjustment for the win odds is possible, leading to potentially more precise estimators and larger power as compared to the unadjusted win odds. We present the underlying theory for covariate adjustment for the win odds in an accessible way and apply the method on synthetic data based on the CANTOS trial ( ClinicalTrials.gov identifier: NCT01327846) characteristics, on a subset of the HF‐ACTION trial data ( ClinicalTrials.gov identifier: NCT00047437), and on simulated data to study the operating characteristics of the method. We observe that there is indeed a potential gain in power when the win odds is adjusted for baseline covariates if the baseline covariates are prognostic for the outcome. This comes at the cost of a slight inflation of the type I error rate for small sample sizes.
JASA Networks & Graphs Causal Inference · 发表于 2026-05-15,收录于 2026-05-16
Cornelius Fritz, Michael Schweinberger, Subhankar Bhadra, David R. Hunter
摘要
To understand how the interconnected and interdependent world of the twenty-first century operates and make model-based predictions, joint probability models for networks and interdependent outcomes are needed. We propose a comprehensive regression framework for networks and interdependent outcomes with multiple advantages, including interpretability, scalability, and provable theoretical guarantees. The regression framework can be used for studying relationships among attributes of connected units and captures complex dependencies among connections and attributes, while retaining the virtues of linear regression, logistic regression, and other regression models by being interpretable and widely applicable. On the computational side, we show that the regression framework is amenable to scalable statistical computing based on convex optimization of pseudo-likelihoods using minorization-maximization methods. On the theoretical side, we establish convergence rates for pseudo-likelihood estimators based on a single observation of dependent connections and attributes. We demonstrate the regression framework using simulations and an application to hate speech on the social media platform X. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction Longitudinal Data Genetics & Omics · 发表于 2026-05-14,收录于 2026-05-17
Haotian Zou, Rima Kaddurah‐Daouk, Sheng Luo
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose molecular mechanisms involve multiple biological pathways. Longitudinal blood‐based omics data, such as lipidomics and metabolomics profiles, offer promising noninvasive biomarkers for early detection and prognosis, yet they are high‐dimensional, sparse, and exhibit complex temporal and cross‐feature correlations. The primary goal of this study is to identify which omics data types are most strongly associated with time to dementia onset in patients with mild cognitive impairment (MCI) at baseline. To address this, we propose a longitudinal sparse single‐omics factor analysis (LS‐SOFA) framework that models each omics view through view‐specific latent factors and feature‐weight matrices, with temporal dynamics captured by functional principal component analysis (FPCA). The resulting functional principal component (FPC) scores are incorporated into a survival model to test whether each omics view is associated with time to dementia onset. An efficient covariance‐based estimation algorithm substantially reduces computational and memory cost, enabling large‐scale application in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. In simulations, LS‐SOFA achieves higher longitudinal estimation accuracy and more stable hypothesis testing than competing methods. Applied to five blood‐based omics views from ADNI, LS‐SOFA identified plasma lipidomics and serum metabolomics from FIA and UPLC as significantly associated with dementia risk after FDR adjustment, with nominal evidence of association for gut microbial metabolomics from serum. The top features within each omics view reveal biologically interpretable metabolic pathways that may serve as blood‐based biomarkers for AD progression.
Biometrics Clinical Trials Nonparametric & Semiparametric Causal Inference · 发表于 2026-05-14,收录于 2026-05-17
Likun Zhang, Wei Ma
摘要
Identifying treatment-covariate interaction is an initial step toward revealing treatment effect heterogeneity and advancing precision medicine. However, when the covariate of interest is continuous, the definition of treatment-covariate interaction can be ambiguous or rely on questionable model assumptions. To tackle this challenge, we introduce a model-free framework for interaction analysis in randomized controlled trials, advocating the adoption of a clearly defined target parameter for interaction and thereby avoiding assumptions about the functional form of the data-generating mechanism. To ensure feasibility for most randomized controlled trials encountered in practice, we study interaction analysis under covariate-adaptive randomization, including simple and stratified randomization, and minimization methods. We observe that the usual method for interaction analysis can either exaggerate or understate uncertainty, leading to asymptotically conservative or anti-conservative results. We modify the usual method with a consistent variance estimator. Furthermore, by acknowledging the dependence structure of treatment assignment induced by covariate-adaptive randomization, we compute the semiparametric efficiency bound and introduce a novel semiparametric efficient method for analyzing our specified interaction effect. We demonstrate that our semiparametric efficient inference procedure, equipped with nonparametric and machine learning techniques for adjusting baseline covariate information, is both efficient and widely applicable.
SiM Missing Data & Measurement Error Nonparametric & Semiparametric Econometrics & Economics · 发表于 2026-05-14,收录于 2026-05-17
Caihong Qin, Lan Xue, Ufuk Beyaztas, Roger S. Zoh, Mark Benden, Jeff Goldsmith, Carmen D. Tekwe
摘要
Wearable devices collect time‐varying biobehavioral data, offering opportunities to investigate how behaviors influence health outcomes. However, these data often contain measurement error and excess zeros (due to nonwear, sedentary behavior, or connectivity issues), each characterized by subject‐specific distributions. Current statistical methods fail to address these issues simultaneously. We introduce a novel modeling framework for zero‐inflated and error‐prone functional data by incorporating a subject‐specific time‐varying validity indicator that explicitly distinguishes structural zeros from intrinsic values. We iteratively estimate the latent functional covariates and zero‐inflation probabilities via maximum likelihood, using basis expansions and linear mixed models to adjust for measurement error. To assess the effects of the recovered latent covariates, we apply joint quantile regression across multiple quantile levels. Through extensive simulations, we demonstrate that our approach significantly improves estimation accuracy over methods that only address measurement error, and joint estimation yields substantial improvements compared with fitting separate quantile regressions. Applied to a childhood obesity study, our approach effectively corrects for zero inflation and measurement error in step counts, yielding results that closely align with energy expenditure and supporting their use as a proxy for physical activity.
SiM Bayesian Methods Spatial & Time Series Latent Variables & Mixtures · 发表于 2026-05-14,收录于 2026-05-17
Ruiman Zhong, Erick A. Chacón‐Montalván, Paula Moraga
摘要
(verbatim from arXiv:2407.12633 — onlinelibrary.wiley.com returned 403, so this is the preprint abstract; exact online date not confirmed)*: "The ability to accurately cluster contiguous regions with similar disease risk evolution is crucial for effective public health response and resource allocation. In this article, we propose a novel spatial functional clustering model designed for disease risk mapping, utilizing random spanning trees for partitioning and latent Gaussian models for capturing within-cluster structure. This approach enables the identification of spatially contiguous clusters with similar latent functions, representing diverse processes such as trends, seasonality, smooth patterns, and autoregressive behaviors. Our method extends the application of random spanning trees to cases where the response variable belongs to the exponential family, making it suitable for a wide range of realworld scenarios, including non-Gaussian likelihoods. The proposed model addresses the limitations of previous spatial clustering methods by allowing all within-cluster model parameters to be cluster-specific, thus offering greater flexibility. Additionally, we propose a Bayesian inference algorithm that overcomes the computational challenges associated with the reversible jump Markov chain Monte Carlo (RJ-MCMC) algorithm by employing composition sampling and the integrated nested Laplace approximation (INLA) to compute the marginal distribution necessary for the acceptance probability. This enhancement improves the mixing and feasibility of Bayesian inference for complex models. We demonstrate the effectiveness of our approach through simulation studies and apply it to real-world disease mapping applications: COVID-19 in the United States of America, and dengue fever in the states of Minas Gerais and São Paulo, Brazil. Our results highlight the model's capability to uncover meaningful spatial patterns and temporal dynamics in disease outbreaks, providing valuable insights for public health decision-making and resource allocation.
SiM Latent Variables & Mixtures · 发表于 2026-05-14,收录于 2026-05-17
Kelsey A. L. Alexovitz, Brisa N. Sánchez, Emma V. Sanchez‐Vaznaugh
摘要
While the creation of latent classes and how they transition over time is useful in describing heterogeneity in a population, examining their relation to other external variables, such as distal outcomes, is often of main interest. There are multiple methods of determining the association between latent classes and distal outcomes. Using modal class assignment as a predictor of the distal outcome is the simplest approach, but these associations suffer from bias due to classification error when assigning latent classes. Other common methods, including the biased‐adjusted 3‐step maximum likelihood or BCH approaches, remove the bias but struggle computationally when estimating associations using complex data structures, such as a larger number of time points or multilevel distal outcomes. We propose a biased‐adjusted 3‐step BCH‐GEE approach that can be used for a multilevel repeated cross‐sectional design. In this approach, latent transition analysis is used to model time‐varying latent classes, followed by ascertainment of classification errors, and weighted GEE to estimate the association between the latent classes and the multilevel distal outcomes. Simulation studies show that the proposed method corrects the bias of the effect estimates that otherwise occur due to the classification error when assigning latent classes. We use this method to examine the association between time‐varying school neighborhood unhealthy food environment classes in California and measures of students' body mass index in 5th grade over an 8 year time‐frame. Results show that children attending schools in neighborhood environments with a higher density of unhealthy food outlets have higher body mass index.
SiM Other · 发表于 2026-05-14,收录于 2026-05-17
Malka Gorfine, Richard J. Cook, Per Kragh Andersen, Terry M. Therneau, Pierre Joly, Hein Putter, Maja Pohar Perme, Michal Abrahamowicz
摘要
Multistate models offer a powerful framework for studying disease processes and can be used to formulate intensity‐based and more descriptive marginal regression models. They also represent a natural foundation for the construction of joint models for disease processes and dynamic marker processes, as well as joint models incorporating random censoring and intermittent observation times. This article reviews the ways multistate models can be formed and fitted to life history data. Recent work on pseudo‐values and the incorporation of random effects to model dependence on the process history and between‐process heterogeneity are also discussed. The software available to facilitate such analyses is listed.
SMMR Clinical Trials Survival Analysis Bayesian Methods · 发表于 2026-05-14,收录于 2026-07-24
Not available
摘要
Motivated by a real-world drug development program, we propose a Bayesian phase I/II platform design to co-develop therapies with time-to-event efficacy endpoint (BPCT). We jointly model the binary toxicity outcome and the time-to-event efficacy outcome, leveraging a Bayesian hierarchical framework to enable information sharing across indications. At each interim, we update the dose-toxicity and dose-efficacy estimates, as well as the utility for risk–benefit tradeoffs, based on observed data from all indications. This approach informs indication-specific decisions for dose escalation and de-escalation, and identifies the optimal biological dose for each indication. Simulation studies show that the proposed design has desirable operating characteristics, providing a highly flexible and efficient approach for dose optimization. The design has great potential to shorten the drug development timeline, save cost by reducing overlapping infrastructure, and expedite regulatory approval.
JASA Causal Inference Optimization & Learning Theory · 发表于 2026-05-13,收录于 2026-05-17
Christopher Harshaw, Joel Middleton, Fredrik Sävje
摘要
Unbiased and consistent variance estimators generally do not exist for design-based treatment effect estimators because experimenters never observe more than one potential outcome for any unit. The problem is exacerbated by interference and complex experimental designs. Experimenters must accept conservative variance estimators in these settings, but they can strive to minimize the conservativeness. In this paper, we show that the task of constructing a minimally conservative variance estimator can be interpreted as an optimization problem that aims to find the lowest estimable upper bound of the true variance given the experimenter’s risk preferences and knowledge of the potential outcomes. We characterize the set of admissible bounds in the class of quadratic forms, and we demonstrate that the optimization problem is a convex program for many natural objectives. The resulting variance estimators are guaranteed to be conservative regardless of whether the background knowledge used to construct the bound is correct, but the estimators are less conservative if the provided information is reasonably accurate. Numerical results show that the resulting variance estimators can be considerably less conservative than existing estimators, allowing experimenters to draw more informative inferences about treatment effects. *(abstract via OpenAlex)*
Biometrics Meta-Analysis & Data Integration · 发表于 2026-05-13,收录于 2026-05-17
Glen McGee, Joseph Antonelli
摘要
An important goal of environmental health research is to assess the health risks posed by mixtures of multiple environmental exposures. In these mixtures analyses, flexible models such as Bayesian kernel machine regression and multiple index models are appealing because they allow for arbitrary non-linear exposure-outcome relationships. However, this flexibility comes at the cost of low power, particularly when exposures are highly correlated and the health effects are weak, as is typical in environmental health studies. We propose a multivariate index modeling strategy that borrows strength across exposures and outcomes by exploiting similar mixture component weights and exposure-response relationships. In the special case of distributed lag models, in which exposures are measured repeatedly over time, we jointly encourage co-clustering of lag profiles and exposure-response curves to more efficiently identify critical windows of vulnerability and characterize important exposure effects. We then extend the proposed approach to the multiple index model setting where the true index structure—the number of indices and their composition—is unknown, and introduce variable importance measures to quantify component contributions to mixture effects. Using time series data from the National Morbidity, Mortality and Air Pollution Study, we demonstrate the proposed methods by jointly modeling three mortality outcomes and two cumulative air pollution measurements with a maximum lag of 14 days.
Biometrics Genetics & Omics Longitudinal Data · 发表于 2026-05-13,收录于 2026-05-17
Mengyu He, Ni Zhao
Biometrics Bayesian Methods · 发表于 2026-05-12,收录于 2026-05-17
Aaron Sonabend-W, Jiangshan Zhang, Edgar Castro, Joel Schwartz, Brent A Coull, Junwei Lu
摘要
Humans are exposed to complex mixtures of environmental pollutants rather than single chemicals, necessitating methods to quantify the health effects of such mixtures. Research on environmental mixtures provides insights into realistic exposure scenarios, informing regulatory policies that better protect public health. However, statistical challenges, including complex correlations among pollutants and nonlinear multivariate exposure-response relationships, complicate such analyses. A popular Bayesian semi-parametric Gaussian process regression framework addresses these challenges by modeling exposure-response functions with Gaussian processes and performing feature selection to manage high-dimensional exposures while accounting for confounders. Originally designed for small to moderate-sized cohort studies, this framework does not scale well to massive datasets. To address this, we propose a divide-and-conquer strategy, partitioning data, computing posterior distributions in parallel, and combining results using the generalized median. While we focus on Gaussian process models for environmental mixtures, the proposed distributed computing strategy is broadly applicable to other Bayesian models with computationally prohibitive full-sample Markov Chain Monte Carlo fitting. We apply this method to estimate associations between a mixture of ambient air pollutants and 650 000 birthweights recorded in Massachusetts during 2001–2012. Our results reveal negative associations between birthweight and traffic pollution markers, including elemental and organic carbon and PM$_{2.5}$, and positive associations with ozone and vegetation greenness.
Biometrics Survival Analysis · 发表于 2026-05-12,收录于 2026-05-17
Dingning Liu, Shuai Chen
摘要
Cost-effectiveness analysis (CEA) is crucial for evaluating new medical treatments. In many studies, both costs and effectiveness are censored. While standard survival analysis methods suit survival time, they cannot be directly applied to cumulative outcomes (e.g., costs or quality-adjusted lifetime) due to induced informative censoring. Additional challenges arise when costs and effectiveness have different terminating events or censoring times. Our motivating examples are two cardiovascular trials: MADIT-CRT and MADIT-II. In MADIT-CRT, effectiveness was defined as heart failure-free survival, while costs accumulated until death, leading to different terminating events for costs and effectiveness. Furthermore, subgroup identification for patient heterogeneity was also of interest. In MADIT-II, early stopping of cost collection for some patients complicated CEA. These examples highlight the need for methods handling different censoring structures while allowing covariate adjustment to improve efficiency and address imperfect randomization. Although some CEA methods have been proposed for different terminating events or censoring times, none provide covariate adjustment. We propose regression-based methods for CEA with different terminating events or censoring times, focusing on estimating the incremental cost-effectiveness ratio and the incremental net benefit. By incorporating covariates within a regression framework, our methods enable covariate adjustment and subgroup identification. Simulation studies demonstrate good finite-sample performance, and applications to the two motivating examples show that our approach provides practical tools for CEA under complex censoring mechanisms.
SiM Longitudinal Data · 发表于 2026-05-12,收录于 2026-05-17
Yi Zhou, Taojun Hu, Yuji Sakamoto, Ao Huang, Xiao‐Hua Zhou, Satoshi Hattori
摘要
In systematic reviews and meta‐analyses, publication bias (PB) is one of the serious concerns and mainly induced by selective publication of academic literatures. Although many methods have been proposed to address PB, almost all of them are based on the normal‐normal (NN) random‐effects model, assuming that data are normally distributed at both the within‐study and between‐study levels. For rare‐event meta‐analysis where data contain rare occurrences of events, the standard NN random‐effects model may perform poorly. Instead, some generalized linear mixed models (GLMMs) which employ the exact distribution for the number of events at the within‐study level increase the estimation accuracy and have been widely used in practice. However, limited methods can be applied to address PB in the GLMMs. To address this limitation, we propose a framework of sensitivity analysis for evaluating the impact of PB in the contrast‐based GLMMs. The proposed framework is developed based on the famous Copas‐Heckman‐type sensitivity analysis methods by relating study‐specific true effect sizes with the latent Gaussian variable on the study sample sizes for adjusting PB. The proposed methods completely avoid the need for continuity corrections and can be easily implemented using standard software with low computational cost. Simulation studies are conducted to assess the performance of the proposed methods in adjusting PB and compare the results with related existing methods. Several real‐world examples are also analyzed to show the broad applicability of our proposal in evaluating the potential impact of PB in meta‐analysis of odds ratios and proportions with rare‐event outcomes.
JASA Bayesian Methods · 发表于 2026-05-11,收录于 2026-05-17
Yuliang Xu, Timothy D. Johnson, Thomas E. Nichols, Jian Kang
摘要
Bayesian Image-on-Scalar Regression (ISR) offers significant advantages for neuroimaging data analysis, including flexibility and the ability to quantify uncertainty. However, its application to large-scale imaging datasets, such as found in the UK Biobank, is hindered by the computational demands of traditional posterior computation methods, as well as the challenge of individual-specific brain masks that deviate from the common mask typically used in standard ISR approaches. To address these challenges, we introduce a novel Bayesian ISR model that is scalable and accommodates inconsistent brain masks across subjects in large-scale imaging studies. Our model leverages Gaussian process priors and integrates salience area indicators to facilitate ISR. We develop a cutting-edge scalable posterior computation algorithm that employs stochastic gradient Langevin dynamics coupled with memory mapping techniques, ensuring that computation time scales linearly with subsample size and memory usage is constrained only by the batch size. Our approach uniquely enables direct spatial posterior inferences on brain activation regions. The efficacy of our method is demonstrated through simulations and analysis of the UK Biobank task fMRI data, encompassing 38,639 subjects and over 120,000 voxels per image, showing that it can achieve a speed increase of 4 to 11 times and enhance statistical power by 8% to 18% compared to traditional Gibbs sampling with zero-imputation in various simulation scenarios." (Retrieved from the authors' arXiv preprint of the same paper; tandfonline.com blocked direct access.) *Publication/online date: date unknown*
SiM Longitudinal Data Causal Inference · 发表于 2026-05-09,收录于 2026-06-05
Anja Shahu, Weijie Xia, Ying Wei, Daniel Malinsky
摘要
Longitudinal data often contains outcomes measured at multiple visits, and scientific interest may lie in quantifying the effect of an intervention on an outcome's rate of change. For example, one may wish to study the progression (or trajectory) of a disease over time under different hypothetical interventions. We extend the longitudinal modified treatment policy (LMTP) methodology to estimate effects of complex, exposure‐dependent interventions on rates of change in an outcome over time. We exploit the theoretical properties of a nonparametric efficient influence function (EIF)‐based estimator to introduce a novel inference framework that can be used to construct simultaneous confidence intervals for a variety of causal effects of interest and to formally test relevant global and local hypotheses about rates of change. We demonstrate the utility of our framework in investigating whether a longitudinal shift intervention affects an outcome's counterfactual trajectory, as compared with no intervention. We present results from a simulation study to illustrate the performance of our inference framework in a longitudinal setting with time‐varying confounding and a continuous exposure. We also apply our inference framework to the Columbia Brain Health DataBank (CBDB) to examine the effect of shifting blood pressure on the progression of dementia.
SiM Causal Inference Machine Learning · 发表于 2026-05-09,收录于 2026-05-29
Xiaxian Ou, Xinwei He, David Benkeser, Razieh Nabi
摘要
Racial disparities in healthcare expenditures are well‐documented, yet the underlying drivers remain complex. This study develops a framework to decompose such disparities through shifts in the distributions of mediating variables, rather than treating race itself as a manipulable exposure. We define disparities as differences in covariate‐adjusted outcome distributions across racial groups, and decompose the total disparity into a component attributable to differences in mediator distributions, and a residual component that remains after equalizing those distributions. Using data from the medical expenditures panel survey (MEPS), we examine the extent to which expenditure disparities would persist or be reduced if mediators such as socioeconomic status (SES), insurance access, health behaviors, or health status were equalized across racial groups. To ensure valid inference, we derive asymptotically linear estimators based on influence‐function techniques and flexible machine learning, including super learners and a two‐part model designed for the zero‐inflated, right‐skewed nature of expenditure data. Applying this framework to MEPS data from 2009 to 2016, substantial disparities were observed across all pairwise racial comparisons, with the largest gaps observed between non‐Hispanic Whites and Hispanics in both years. Differences in SES and health status were the largest contributors to these disparities, with insurance access also playing a meaningful role, particularly for Hispanic populations, whereas health behaviors contributed minimally. Residual disparities persisted, especially in comparisons involving non‐Hispanic Whites, suggesting the influence of unmeasured or structural factors.
SiM Testing & Uncertainty Clinical Trials · 发表于 2026-05-08,收录于 2026-05-17
Tianyu Zhan, Yabing Mai, Yihua Gu, Thao Doan, Xun Chen
摘要
Safety assessment plays a fundamental role in developing a new drug via clinical trials for ethical considerations. Due to complexity, manual review is typically conducted on the totality of data to draw safety conclusions. There are some existing quantitative methods to facilitate or tailor further medical review, with a controlled error rate and integration of clinical knowledge. In addition to those two key aspects, we emphasize the importance of relying on substantial evidence to draw robust conclusions on safety. Motivated by these three important properties, we propose a two‐layer Synergy Area with FDR‐controlled Evaluation (SAFE) structural framework to robustly assess the safety profile in clinical trials. In the first layer of SAFE, we investigate each clinically meaningful Synergy Area (SA) based on compelling evidence. In the next layer, the false discovery rate (FDR) is controlled for potential findings across all SAs. Simulation studies show that SAFE properly controls error rates within and across SAs at the nominal level. We further apply the proposed approach to two case studies based on real data from the Historical Trial Data (HTD) Sharing Initiative of the DataCelerate platform. As compared to some direct methods, SAFE demonstrates an appealing feature of screening out extreme data and reaching solid safety conclusions. It can act as either a building block in another framework, or a platform to incorporate additional components.
SiM Clinical Trials Bayesian Methods · 发表于 2026-05-08,收录于 2026-05-22
Lindsey E. Turner, Carolyn T. Bramante, Thomas A. Murray
摘要
In randomized controlled trials, ordinal outcomes typically improve statistical efficiency over binary outcomes. The treatment effect on an ordinal outcome is usually described by the odds ratio from a proportional odds model, but this summary measure lacks transparency with respect to its emphasis on the components of the ordinal outcome when proportional odds is violated. We propose various summary measures for ordinal outcomes that are fully transparent in this regard, including ‘weighted geometric mean’ odds ratios and relative risks, and ‘weighted mean’ risk differences. We also develop and evaluate efficient model‐assisted Bayesian estimators for these population‐level summary measures based on nonproportional odds models that facilitate covariate adjustment with marginalization via the Bayesian bootstrap. We propose a weighting scheme that engenders appealing heuristic properties, including invariance to whether the ordinal outcome is ordered from best to worst versus worst to best. Using computer simulation, we show that comparative testing based on the proposed population‐level summary measures performs well relative to a proportional odds approach. We also report an analysis of the COVID‐OUT trial, which exhibits evidence of a nonproportional odds treatment effect.
SiM Survival Analysis · 发表于 2026-05-08,收录于 2026-05-17
Nasrin Sultana, Moudud Alam, Md Hasinur Rahaman Khan
摘要
Advancements in modern medical technology have enabled cures for a fraction of patients while extending survival times for those who are not cured. For non‐cured patients, disease recurrence is influenced by observed covariates and unobserved individual heterogeneity (random effects). In biomedical studies, dependent censoring is frequently encountered, for example, in cancer patients, where right censoring can be caused by death from unrelated diseases or due to an (unobservable) cure status. This study introduces a joint frailty model for recurrent event data with a cure fraction, effectively capturing heterogeneity and inducing dependent censoring. The proposed multivariate joint frailty mixture cure models incorporate covariates and frailties, together with the event incidence time and latent cure status. The model accounts for the probability of a cure after each recurrence using both the complementary log–log and the logistic link function. A likelihood‐based estimation method is developed using the Monte Carlo Expectation‐Maximization (MCEM) algorithm. Through Monte Carlo simulation, we examine the finite sample properties of the MCEM estimators, supplemented by a real‐world application using secondary data on hospital readmissions for colorectal cancer recurrence post‐surgery. Simulation results suggest lifetime and frailty parameter estimates are unbiased and consistent. Compared to models with identical frailty structure, both the complementary log–log and the logistic cure frailty models with dependent frailties demonstrate a better fit with the real data, as evidenced by lower Akaike information criteria values.
SiM Other · 发表于 2026-05-08
Not available
SiM Genetics & Omics High-Dimensional Econometrics & Economics · 发表于 2026-05-08,收录于 2026-05-17
Zhuoqun Wang, Jialiang Mao, Li Ma
摘要
Microbiome compositional data are often high‐dimensional, sparse, and exhibit pervasive cross‐sample heterogeneity. We introduce the “logistic‐tree normal” (LTN) model, a generative model that allows flexible covariance among the microbiome taxa, enables scalable computation, and effectively captures other key characteristics of microbiome compositional data such as the abundance of zeros. LTN incorporates a tree‐based decomposition for effective aggregation over sparse taxa counts and models the relative abundance at the tree splits jointly using a (multivariate) logistic‐normal distribution. The latent Gaussian structure allows a wide range of multivariate analysis and modeling tools for high‐dimensional data—such as those enforcing sparsity or low‐rank assumptions on the covariance structure—to be readily incorporated. As a general‐purpose, fully generative model, LTN can be applied in a wide range of contexts, while at the same time, efficient computational recipes for Bayesian inference under LTN are available through conjugate blocked Gibbs sampling enabled by pólya‐gamma augmentation. We demonstrate the use of LTN in a compositional mixed‐effects model for differential abundance analysis through both numerical experiments and a reanalysis of the infant cohort in the DIABIMMUNE study. We explain and showcase through numerical experiments and the case study how LTN, through adequately accounting for the cross‐sample heterogeneity, is capable of generating the appropriate proportion of zeros without incurring an explicit zero‐inflation component. This confirms a recent viewpoint that “zero‐inflation” in count‐based sequencing data are often results of unaccounted cross‐sample variation.
SMMR Survey & Sampling Machine Learning Networks & Graphs · 发表于 2026-05-07
Marcos Matabuena, Juan C Vidal, Rahul Ghosal, Jukka-Pekka Onnela
摘要
Complex survey designs are widely used in medical cohort studies. Developing risk score models that adequately account for the sampling design is essential to minimize selection bias and obtain representative population estimates. This work addresses three complementary objectives. First, we propose a general predictive framework for regression and classification tasks that utilizes neural networks to incorporate survey weights into the model estimation process. Second, we introduce a procedure for quantifying prediction uncertainty based on conformal inference, adapted to the characteristics of complex survey data. Third, we demonstrate the application of the proposed methodology in a case study assessing the risk of diabetes mellitus in the US population, using the NHANES 2011–2014 cohort. The empirical results show that models of varying complexity, each using different sets of predictors, achieve different trade-offs between predictive performance and economic cost while maintaining generalizability at the population level. Although the case study focuses on diabetes, the proposed framework is directly applicable to the development of clinical prediction models for other diseases and complex survey datasets. All software and data used in this study are publicly available on GitHub.
SiM Clinical Trials · 发表于 2026-05-05,收录于 2026-05-08
Moreno Ursino, Sandrine Boulet, Corinne Collignon, Florence Francis‐Oliviero, Edouard Lhomme, Raphaël Porcher, Florence Saillour, Gaël Varoquaux, Vincent Vercamer, Rodolphe Thiébaut, Sarah Zohar
摘要
To address patient demand for rapid access to innovative digital medical devices (DMDs), several health technology assessment (HTA) authorities in European Union countries provide transitional or provisional access and reimbursement pathways. These pathways are available when only incomplete clinical trial data are accessible, and significant uncertainty remains regarding the clinical benefits, even after CE (European conformity) marking has been obtained. Once manufacturers complete the clinical studies, additional real‐world data (RWD) may become available as a result of the device's use in the target population. Consequently, regulators can draw on both sources of information to support their final decision‐making processes. For a statistically principled evaluation of such settings, we propose a statistical framework suitable for DMD evaluation under European HTA fast‐track requirements, integrating both clinical trial data and RWD. The framework consists of three key steps: (1) an interim analysis of clinical trial data, which can support temporary regulatory authorization and enable the collection of RWD; (2) a final analysis of the clinical trial data; and (3) a meta‐analysis combining the clinical trial data and RWD, contingent upon obtaining temporary authorization. To optimize the timing of the interim analysis and the application for temporary authorization, we introduce several metrics. The proposed framework was assessed by means of an extensive simulation study. This framework should be complemented by a post‐market evaluation of the DMD once it has been widely adopted, aligning with the principles of phase IV studies.
SiM Survival Analysis Clinical Trials Causal Inference · 发表于 2026-05-05,收录于 2026-05-29
Xi Fang, Bingkai Wang, Guangyu Tong, Liangyuan Hu, Shuangge Ma, Fan Li
摘要
Progressive multi‐state survival outcomes are common in trials with recurrent or sequential events and require treatment effect estimands that remain interpretable without proportional intensity or Markov assumptions. The restricted mean time in favor of treatment (RMT‐IF) extends the restricted mean survival time to ordered multi‐state processes and provides such an interpretable estimand. However, existing RMT‐IF methods are nonparametric, assume covariate‐independent censoring for independent observations, and do not accommodate cluster‐randomized trials (CRTs), limiting both efficiency and applicability. We develop a class of doubly robust estimators for RMT‐IF under right censoring using an augmented inverse‐probability weighting framework that combines stage‐specific outcome regression with arm‐specific censoring models, yielding consistency when either nuisance model is correctly specified. We further extend the framework to CRTs by formalizing both cluster‐level and individual‐level average RMT‐IF estimands to address informative cluster size and by constructing corresponding doubly robust estimators that account for within‐cluster correlation. For inference, we employ model‐agnostic jackknife variance estimators in both individually randomized and cluster‐randomized settings. Extensive simulation studies demonstrate finite‐sample performance, and the methods are illustrated using two randomized trial examples.